Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Category

1 … 3 4 5 … 9

The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

Research Presented at the Annual CMSC Meeting - May 31 - June 3, 2023

Detection of Silent UTI – a Case Study

Research Presented at the Annual CMSC Meeting - May 31 - June 3, 2023

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

Research Presented at the Annual CMSC Meeting - May 31 - June 3, 2023

CMSC 2023 The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

CMSC 2023 Detection of Silent UTI – A Case Study

CMSC 2023 Variability of Longitudinal Standard of Care Brain MRI Scans Ordered By a Single MS Center

CMSC 2023 Variability of Longitudinal Standard of Care Brain MRI Scans Ordered By a Single MS Center

Disease Modifying Therapy in Newly Diagnosed People with Multiple Sclerosis – A Real-World Administrative Claims Study

Research Presented at the Annual AAN Meeting - April 22-27, 2023

Analytical Validation of a Multi-Protein, Serum-Based Assay for Disease Activity Assessments in Multiple Sclerosis

Study Published in Proteomics Clinical Applications

Real-World Evidence of Tysabri (Natalizumab) Dose Interval Trends in People with Multiple Sclerosis from Administrative Claims Data

Research Presented at the Annual AMCP Meeting - March 21-24, 2023